✦ LIBER ✦

A symposium: Safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of Acute Coronary Syndromes

✍ Scribed by James E. Tcheng

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet glycoprotein IIb/IIIa inhibitor

✍ Juris J Meier; Baptist Gallwitz; Wolfgang E Schmidt; Michael A Nauck 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 46 KB

Platelet glycoprotein IIb/IIIa inhibitor

✍ Eric Boersma; Robert A Harrington; David J Moliterno; Harvey White; Maarten L Si 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 89 KB

Overview of clinical trials of glycoprot

✍ Robert A. Harrington 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 207 KB

The role of glycoprotein IIb/IIIa inhibi

✍ Colleen F. Koller 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 124 KB

A prospective analysis of complications

✍ RM Rocha,CT Mesquita,MCFS Kanto,FS Lugão,AL Cascardo,PS Lira… 📂 Article 📅 2001 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 831 KB

Evaluating the benefits of glycoprotein

✍ Monvadi B Srichai; Wael A Jaber; David L Prior; Steven P Marso; Penny L Houghtal 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 135 KB